Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes: Response to a letter from Dr. Maurie Markman

Gynecologic Oncology

Volumn 101, Issue 3, 2006, Pages 551-552

  Bristow, Robert E ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CYTOREDUCTIVE SURGERY; DIAGNOSTIC ACCURACY; HUMAN; LETTER; OVARY CANCER; PARAAORTIC LYMPH NODE; PRIORITY JOURNAL; RECURRENT CANCER;

EID: 33646566783     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.01.053     Document Type: Letter

References (11)

1. Markman M. Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes. Gynecol. Oncol. (2006) [in press]
2. Janicke F., Holscher M., Kuhn W., von Hugo R., Pache L., Siewert J.R., et al. Radical surgical procedure improves survival time in patients with recurrent ovarian cancer. Cancer 70 (1992) 2129-2136
3. Eisenkop S.M., Friedman R.L., and Wang H.J. Secondary cytoreductive surgery for recurrent ovarian cancer: a prospective study. Cancer 76 (1995) 1606-1614
4. Gadducci A., Iacconi P., Cosio S., Fanucchi A., Cristofani R., and Riccardo Gennazani A. Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer. Gynecol. Oncol. 79 (2000) 344-349
5. Eisenkop S.M., Friedman R.L., and Spirtos N.M. The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma. Cancer 88 (2000) 144-153
6. Scarabelli C., Gallo A., and Carbone A. Secondary cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma. Gynecol. Oncol. 83 (2001) 504-512
7. Tay E.H., Grant P.T., Gebski V., and Hacker N.F. Secondary cytoreductive surgery for recurrent epithelial ovarian cancer. Obstet. Gynecol. 99 (2002) 1008-1013
8. Onda T., Yoshikawa H., Yasugi T., Yamada M., Matsumoto K., and Taketani Y. Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: proposal for patients selection. Br. J. Cancer 92 (2005) 1026-1032
9. Rose P., Nerenstone S., Brady M.F., Clarke-Pearson D., Olt G., Rubin S.C., et al. Secondary surgical cytoreduction for advanced ovarian carcinoma. N. Engl. J. Med. 351 (2004) 2489-2497
10. Greer B.E., Bundy B.N., Ozols R.F., Fowler J.M., Clarke-Pearson D., Burger R.A., et al. Implications of second-look laparotomy in the context of optimally resected stage III ovarian cancer: a non-randomized comparison using an exploratory analysis: a Gynecologic Oncology Group study. Gynecol. Oncol. 99 (2005) 71-79
11. Eisenkop S.M., and Spirtos N.M. The clinical significance of occult macroscopically positive retroperitoneal nodes in patients with epithelial ovarian cancer. Gynecol. Oncol. 82 (2001) 143-149